| Wednesday, January 12, 2022 | |
|---|---|
| 8:00 am – 5:00 pm | Poster Hall Setup |
| 9:00 am – 8:30 pm | Registration Opens |
| 6:00 pm – 8:00 pm | Welcome Reception Poster Hall Open |
| Thursday, January 13, 2022 | |
|---|---|
| 7:30 am – 6:30 pm | Registration/Information |
| 7:30 am – 8:30 am | Breakfast Poster Hall Open |
| 8:30 am – 12:00 noon | Plenary Session |
| 8:30 am – 8:45 am | Opening Session |
| 8:45 am – 9:30 am | Physiologic Considerations for Novel BoNT–Based Therapeutics and Indications (Improving BoNT Targeting) Keynote Speaker: Min Dong, PhD |
| 9:30 am – 10:00 am | Focus on BoNT Engineering (Phage–Assisted Evolution of Botulinum Neurotoxin Proteases with Reprogrammed Specificity) Travis Blum, PhD |
| 10:00 am – 10:30 am | Basis of Movement Control and Why Botulinum Toxin Should Influence It Aparna Wagle Shukla, MD |
| 10:30 am – 11:00 am | Break Poster Hall Open |
| 11:00 am – 12:00 noon | Botulinum Toxin in the COVID Era: Issues and Challenges Chris Boulias, MD, PhD Barbara Karp, MD David Simpson, MD |
| 12:00 noon – 2:00 pm | Break Poster Hall Open |
| Time | Basic Science Track | Time | Clinical Track 1A | Time | Clinical Track 2A | Time | Clinical Track 3A | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2:00 pm – 3:35 pm | History, Genetics, and Evolution | 2:00 pm – 3:35 pm | Spasticity | 2:00 pm – 3:35 pm | Cervical Dystonia & Focal Limb Dystonia | 2:00 pm – 3:35 pm | Aesthetic Medicine and Dermatology | ||||||
| 2:00 pm – 2:25 pm | The First FDA Approved Batches of Pharmaceutical Botulinum Toxin Eric Johnson, ScD |
2:00 pm – 2:25 pm | What's New? BoNT Clinical Trial Update: Adult Spasticity Gerard Francisco, MD |
2:00 pm – 2:20 pm | What's New? BoNT Clinical Trial Update: Cervical Dystonia Cindy Comella, MD |
2:00 pm – 2:35 pm | Essential Anatomy and Injection Technique: Neuromodulators for Aesthetic Use in the Upper, Mid and Lower Face Steven Yoelin, MD Wendy Lee, MD |
||||||
| 2:25 pm – 2:50 pm | Geographical Distribution of C. botulinum Phyla Carolina Luquez, PhD |
2:25 pm – 2:45 pm | Gait Pattern Recognition and Muscle Selection for BoNT Injections Alberto Esquenazi, MD |
2:20 pm – 2:40 pm | Anatomy and Ultrasound-Guided Injection of Deep Neck Muscles for Anterocollis Katharine Alter, MD |
2:35 pm – 2:55 pm | Clinical Implications of the Long-Term Use of Neuromodulators for Aesthetic Indications Michael Kane, MD |
||||||
| 2:50 pm – 3:15 pm | Chromosomally Integrated Plasmids in G1 C. botulinum Kristin Schill, PhD |
2:45 pm – 3:05 pm | What Are We Missing? It’s More Than Injections Laura Wiggs, PT, NCS, CBIS |
2:40 pm – 3:00 pm | Focal Limb Dystonia and Tremor: A Look at the BoNT Data |
2:55 pm - 3:10 pm | Panel Discussion Michael Kane, MD Wendy Lee, MD Nowell Solish, MD Steven Yoelin, MD |
||||||
| 3:15 pm – 3:35 pm | 2 Selected Abstracts |
3:05 pm - 3:20 pm | Balancing Dosing in Patients Who Need More Than You Can Give Cindy Ivanhoe, MD |
3:00 pm - 3:20 pm | Focal Limb Dystonia: Focus on Injection Technique David Simpson, MD |
3:10 pm - 3:35 pm | 2 Selected Abstracts |
||||||
| 3:20 pm – 3:35 pm | 2 Selected Abstracts |
3:20 pm – 3:35 pm | 2 Selected Abstracts |
||||||||||
| 3:35 pm – 3:55 pm | Break Poster Hall Open |
3:35 pm – 3:55 pm | Break Poster Hall Open |
3:35 pm – 3:55 pm | Break Poster Hall Open |
3:35 pm – 3:55 pm | Break Poster Hall Open |
||||||
| Time | Basic Science Track | Time | Clinical Track 1B | Time | Clinical Track 2B | Time | Clinical Track 3B | Time | Injection Demonstration Workshop | ||||
| 3:55 pm – 5:30 pm | Toxin Engineering and Pharmacokinetics |
3:55 pm – 5:30 pm | Oromandibular Dystonia (OMD), Spasmodic Dysphonia, Blepharospasm, and Meige Syndrome | 3:55 pm – 5:25 pm | Practical Considerations |
3:55 pm – 5:30 pm | Selected Topics I | 3:55 pm – 5:30 pm | Aesthetic Medicine and Dermatology: Round Robin Injection Workshop |
||||
| 3:55 pm – 4:20 pm | Botulinum Neurotoxin Trafficking Within Motor Neurons Patrick M. McNutt, PhD |
3:55 pm – 4:15 pm | Clinical Features of OMD: A Summary of More Than 2000 Cases H. A. Jinnah, MD |
3:55 pm – 4:25 pm | Clinical Aspects Associated With BoNT Properties: Does Altering the Onset of Action and Increasing Duration of Action Really Matter in Clinical Practice? Mark Hallett, MD |
3:55 pm – 4:20 pm | Applications of Botulinum Toxin: The Female Pelvic Floor Barbara Karp, MD |
3:55 pm – 5:30 pm | Deidera O'Boyle Hooper, MD | ||||
| 4:20 pm – 4:45 pm | Spectroscopic Insights Into the Translocation Domain: Membrane Insertion and Refolding of Tetanus Toxin/Cellular Entry of Binary and Pore-Forming Bacterial Toxins |
4:15 pm – 4:35 pm | What's New? BoNT Clinical Trial Update: OMD Nikita Kohli, MD |
4:25 pm – 4:55 pm | Dosing Intervals With BoNT: Managing Multiple Indications and Boosters David Simpson, MD |
4:20 pm – 4:45 pm | Botulinum Toxin in Parkinsonian Disorders Robert Chen, MD |
||||||
| 4:45 pm – 5:10 pm | Engineering BoNTs as Vehicles for Drug Delivery/ Neuronal Delivery Vehicles Using Antibodies for BoNT Intoxication Konstantin Ichtchenko, PhD |
4:35 pm – 4:55 pm | Spasmodic Dysphonia Andrew Blitzer, MD |
4:45 pm – 5:10 pm | Effects of Toxin Non-Motor Symptoms in Dystonia H. A. Jinnah, MD |
||||||||
| 5:10 pm – 5:30 pm | 2 Selected Abstracts |
4:55 pm – 5:20 pm | How to Adjust Expectations and Manage a Newly-Diagnosed Blepharospasm and Meige Syndrome Patient Barbara Karp, MD |
4:55 pm - 5:25 pm | 3 Selected Abstracts | 5:10 pm – 5:30 pm | 2 Selected Abstracts | ||||||
| 5:20 pm – 5:30 pm | 2 Selected Abstracts |
| Friday, January 14, 2022 | |
|---|---|
| 8:00 am – 6:30 pm | Registration/Information |
| 7:30 am – 8:30 am | Breakfast Poster Hall Open |
| 8:30 am – 12:00 noon | Plenary Session |
| 8:30 am – 9:00 am | BoNT as a Treatment Option for Age-Related Macular Degeneration (AMD) |
| 9:00 am – 9:30 am | BoNT in the Management of Neuropathic Pain Nadine Attal, MD, PhD (France) |
| 9:30 am – 10:00 am | The Emerging Role of Botulinum Toxin in Cardiology Jonathan S. Steinberg, MD |
| 10:00 am – 10:30 am | Wound Healing |
| 10:30 am – 11:00 am | Break Poster Hall Open |
| 11:00 am – 12:00 noon | Depression Roundtable: Is there a role for BoNT in the Management of Depression? Moderator: Mark Hallett, MD T.H.C. Krüger, PhD (Germany) Nicholas A. Coles, PhD Ornella Rossetto, PhD (Italy) |
| 12:00 noon – 2:00 pm | Lunch Poster Hall Open |
| Time | Basic Science Track | Time | Injection Demonstration Workshop 1A | Time | Clinical Track 1A | Time | Clinical Track 2A | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 2:00 pm – 3:35 pm | Structural and Functional Aspects of BoNTs | 2:00 pm – 3:35 pm | Pediatric Spasticity |
2:00 pm – 3:35 pm | Headache and Pain |
2:00 pm – 3:35 pm | Aesthetic Medicine and Dermatology |
|||
| 2:00 pm – 2:25 pm | Are Non-Clostridial Homologs Botulinum Neurotoxins? Travis Wentz, PhD |
2:00 pm – 2:30 pm | Results of Upper and Lower Limb Management of Cerebral Palsy: Are There any Differences Related to the Toxin or Injection Technique Used? Katharine Alter, MD |
2:00 pm – 2:30 pm | BoNT for Suppression of Chronic Migraine: What Have We Learned in 10+ Years? John Rothrock, MD |
2:00 pm – 2:35 pm | Update on Hyperhidrosis Dee Anna Glaser, MD |
|||
| 2:25 pm – 2:50 pm | Novel Structure-Function Aspects of Clostridial Neurotoxins, Function Emphasis Andreas Rummel, PhD (Germany) |
2:30 pm – 3:35 pm | Therapeutic Use of BoNT Injection Demonstration Workshop Pediatric Spasticity Ann Tilton, MD |
2:30 pm – 2:50 pm | BoNT, mAbs, and Gepants: Elegant Synergism or Expensive Redundancy? |
|||||
| 2:50 pm – 3:15 pm | Tetanus Toxin cis-Loop Contributes to Light-Chain Translocation Joseph Barbier, PhD |
2:50 pm – 3:05 pm | Use of BoNT in Treating Persistent Post-Traumatic Headache John Rothrock, MD |
2:35 pm – 3:15 pm | Micro Toxin Technique: What, Why and Where? Woffles Wu, FRCS, FAMS |
|||||
| 3:15 pm – 3:35 pm | 2 Selected Abstracts |
3:05 pm – 3:35 pm | 3 Selected Abstracts |
3:15 pm - 3:35 pm | 2 Selected Abstracts |
|||||
| 3:35 pm - 3:55 pm | Break Poster Hall Open |
3:35 pm - 3:55 pm | Break Poster Hall Open |
3:35 pm - 3:55 pm | Break Poster Hall Open |
3:35 pm - 3:55 pm | Break Poster Hall Open |
|||
| Time | Basic Science Track | Time | Injection Demonstration Workshop 1B | Time | Clinical Track 1B | Time | Clinical Track 2B | |||
| 3:55 pm – 5:30 pm | BoNT Detection and Countermeasures |
3:55 pm – 5:30 pm | Cervical Dystonia, Adult Spasticity, and Focal Limb Dystonia |
3:55 pm – 5:30 pm | Selected Topics II | 3:55 pm – 5:30 pm | Aesthetic Medicine and Dermatology |
|||
| 3:55 pm – 4:20 pm | Detection of Select Agent Toxins in Support of Public Health Activities Suzy Kalb, PhD |
3:55 pm – 4:25 pm | Cervical Dystonia |
3:55 pm – 4:20 pm | Clinical Update: The Use of BoNT in the Bladder Roger Dmochowski, MD |
3:55 pm – 4:30 pm | The Use of Neuromodulators for Facial Shaping Woffles Wu, FRCS, FAMS |
|||
| 4:20 pm – 4:45 pm | Peptide Inhibitors of BoNT/A Nick Salzamed, PhD |
4:25 pm – 5:00 pm | Adult Spasticity Shivani Gupta, MD |
4:20 pm – 4:45 pm | Changes in Cortical Excitability and Plasticity After Botulinum Toxin Injecton Robert Chen, MD |
4:30 pm – 5:10 pm | Neuromodulators From Around the World: What’s Here and What’s to Come Nowell Solish, MD |
|||
| 4:45 pm – 5:10 pm | Monoclonal Antibody Combinations for the Prevention and Treatment of Botulism Jim Marks, PhD |
4:45 pm – 5:10 pm | Functional or Psychogenic Dystonia: Should We Inject BoNT? |
5:10 pm – 5:30 pm | 2 Selected Abstracts |
|||||
| 5:10 pm – 5:30 pm | 2 Selected Abstracts | 5:00 pm – 5:35 pm | Focal Limb Dystonia | 5:10 pm - 5:25 pm | 2 Selected Abstracts |
| Saturday, January 15, 2022 | |
|---|---|
| 7:30 am – 12:00 noon | Information |
| 8:00 am – 9:00 am | Breakfast Poster Hall Open |
| 9:00 am – 11:30 am | Plenary Session |
| 9:00 am – 9:45 am | Questions About BoNT You Were Afraid to Ask |
| 9:45 am – 10:15 am | A Look at the Future―New BoNTs and Delivery Systems in Development: A View From the Bench Sabine Pellett, PhD |
| 10:15 am – 10:45 am | A Look at the Future―New BoNTs and Delivery Systems in Development: What it Could Mean in the Clinic |
| 10:45 am – 11:05 am | Best Clinical Abstract |
| 11:05 am – 11:25 am | Best Basic Science Abstract |
| 11:25 am – 11:30 am | Closing Cindy Comella, MD |